NASDAQ:ICCM IceCure Medical (ICCM) Stock Forecast, Price & News $0.61 -0.05 (-7.57%) (As of 09/22/2023 ET) Add Compare Share Share Today's Range$0.61▼$0.6750-Day Range$0.58▼$1.2352-Week Range$0.52▼$4.73Volume351,283 shsAverage Volume218,001 shsMarket Capitalization$27.84 millionP/E RatioN/ADividend YieldN/APrice Target$3.33 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media IceCure Medical MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside446.2% Upside$3.33 Price TargetShort InterestHealthy0.40% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment-0.30Based on 4 Articles This WeekInsider TradingN/AProj. Earnings GrowthDecreasingFrom ($0.36) to ($0.39) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.67 out of 5 starsMedical Sector842nd out of 963 stocksSurgical & Medical Instruments Industry86th out of 97 stocks 3.5 Analyst's Opinion Consensus RatingIceCure Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $3.33, IceCure Medical has a forecasted upside of 446.2% from its current price of $0.61.Amount of Analyst CoverageIceCure Medical has only been the subject of 2 research reports in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted0.40% of the float of IceCure Medical has been sold short.Short Interest Ratio / Days to CoverIceCure Medical has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in IceCure Medical has recently increased by 128.00%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldIceCure Medical does not currently pay a dividend.Dividend GrowthIceCure Medical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for ICCM. Previous Next 1.5 News and Social Media Coverage News SentimentIceCure Medical has a news sentiment score of -0.30. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.52 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for IceCure Medical this week, compared to 1 article on an average week.MarketBeat Follows3 people have added IceCure Medical to their MarketBeat watchlist in the last 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, IceCure Medical insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 2.44% of the stock of IceCure Medical is held by insiders.Percentage Held by InstitutionsOnly 0.34% of the stock of IceCure Medical is held by institutions. Previous Next 0.0 Earnings and Valuation Earnings GrowthEarnings for IceCure Medical are expected to decrease in the coming year, from ($0.36) to ($0.39) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of IceCure Medical is -1.56, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of IceCure Medical is -1.56, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioIceCure Medical has a P/B Ratio of 1.09. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About IceCure Medical (NASDAQ:ICCM) StockIceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a single probe system for the treatment of breast tumors; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.Read More ICCM Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ICCM Stock News HeadlinesSeptember 22, 2023 | finance.yahoo.comRenowned Spanish Radiologist Lucía Graña-López to Present Data Using IceCure Medical's ProSense at European Society of Breast Imaging Scientific Meeting 2023September 21, 2023 | msn.comWhy Is Medical Device Firm IceCure Medical Stock Trading Lower Today?September 24, 2023 | Chaikin Analytics (Ad)His system isolated NVIDIA - Here's His Next Buy.Most investors don't know the truth about A.I. 50-year Wall Street Insider Marc Chaikin reveals what you should be doing to profit. Learn more here.September 20, 2023 | msn.comIceCure Medical shares plunge 40% on FDA updateSeptember 20, 2023 | markets.businessinsider.comIcecure Medical (ICCM) Receives a Buy from H.C. WainwrightSeptember 8, 2023 | finance.yahoo.comIceCure Medical to Join Hands-On Cryoablation Session with ProSense and Host Symposium Led by Renowned Doctors at the CIRCE 2023 Annual CongressSeptember 6, 2023 | markets.businessinsider.comExpert Ratings for Icecure MedicalSeptember 6, 2023 | markets.businessinsider.comH.C. Wainwright Reaffirms Their Buy Rating on Icecure Medical (ICCM)September 24, 2023 | Chaikin Analytics (Ad)His system isolated NVIDIA - Here's His Next Buy.Most investors don't know the truth about A.I. 50-year Wall Street Insider Marc Chaikin reveals what you should be doing to profit. Learn more here.August 31, 2023 | msn.comIcecure Medical (ICCM) Price Target Increased by 37005.92% to 4.01August 28, 2023 | finance.yahoo.comIceCure Medical Takes Next Major Initiative as it Prepares to Accelerate the Commercialization of ProSense in U.S. and Canada: Appoints VP of Sales, North AmericaAugust 21, 2023 | finance.yahoo.comIceCure Medical Continues to Experience Growing Global Interest in ProSense: Featured at the 16th Thai Breast SymposiumAugust 16, 2023 | markets.businessinsider.comIcecure Medical (ICCM) Receives a Buy from Maxim GroupAugust 16, 2023 | finance.yahoo.comIceCure Medical Second Quarter 2023 Earnings: EPS Misses ExpectationsAugust 15, 2023 | msn.comAlliance Global Partners Maintains Icecure Medical (ICCM) Buy RecommendationAugust 15, 2023 | msn.comHC Wainwright & Co. Reiterates Icecure Medical (ICCM) Buy RecommendationAugust 15, 2023 | markets.businessinsider.comH.C. Wainwright Sticks to Their Buy Rating for Icecure Medical (ICCM)August 15, 2023 | markets.businessinsider.comWhat 5 Analyst Ratings Have To Say About Icecure MedicalAugust 14, 2023 | finance.yahoo.comIceCure Medical Reports First Half 2023 Financial & Operational Results: Global Adoption of Cryoablation Technology Gaining MomentumAugust 7, 2023 | finance.yahoo.comIceCure Medical to Report Second Quarter 2023 Financial & Operational Results on August 14, 2023August 1, 2023 | fool.comIceCure Medical (NASDAQ: ICCM)July 27, 2023 | finance.yahoo.comIceCure Medical's (NASDAQ:ICCM) investors will be pleased with their enviable 577% return over the last three yearsJuly 25, 2023 | markets.businessinsider.comMaxim Group Sticks to Their Buy Rating for Icecure Medical (ICCM)July 25, 2023 | markets.businessinsider.comH.C. Wainwright Sticks to Its Buy Rating for Icecure Medical (ICCM)July 24, 2023 | finance.yahoo.comHealth Canada Approves IceCure Medical's Minimally Invasive ProSense Cryoablation SystemJuly 17, 2023 | finance.yahoo.comIceCure Medical Expands Distribution of ProSense® into Portugal Through Agreement with Medicinália Cormédica: Upfront Systems & Probes SalesJune 13, 2023 | finance.yahoo.comIceCure Medical to Review Recent Progress at Maxim Group's Virtual Healthcare ConferenceSee More Headlines Receive ICCM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IceCure Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address ICCM Company Calendar Last Earnings8/14/2023Today9/24/2023Next Earnings (Estimated)12/04/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:ICCM CUSIPN/A CIK1584371 Webwww.icecure-medical.com Phone972-4623-0333Fax972-4623-0222Employees65Year FoundedN/APrice Target and Rating Average Stock Price Forecast$3.33 High Stock Price Forecast$4.00 Low Stock Price Forecast$3.00 Forecasted Upside/Downside+446.2%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($0.39) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-16,980,000.00 Net Margins-486.55% Pretax Margin-550.34% Return on Equity-77.22% Return on Assets-62.76% Debt Debt-to-Equity Ratio0.02 Current Ratio5.30 Quick Ratio4.59 Sales & Book Value Annual Sales$3.09 million Price / Sales9.01 Cash FlowN/A Price / Cash FlowN/A Book Value$0.56 per share Price / Book1.09Miscellaneous Outstanding Shares45,620,000Free Float44,510,000Market Cap$27.84 million OptionableNot Optionable Beta0.11 Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesMr. Eyal Shamir (Age 62)CEO & Director Comp: $467.32kMr. Ronen Tsimerman CPA (Age 54)CFO & COO Comp: $331.8kMs. Tlalit Bussi Tel-Tzure (Age 52)VP of Bus. Devel. & Global Marketing Comp: $279.34kMs. Merav Nir Dotan (Age 54)VP of HR Comp: $197.96kMs. Galit Malik (Age 50)VP of Operations & Service Key CompetitorsNeuroneticsNASDAQ:STIMPAVmedNASDAQ:PAVMDaxorNASDAQ:DXRSensus HealthcareNASDAQ:SRTSRetractable TechnologiesNYSE:RVPView All Competitors ICCM Stock - Frequently Asked Questions Should I buy or sell IceCure Medical stock right now? 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for IceCure Medical in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ICCM shares. View ICCM analyst ratings or view top-rated stocks. What is IceCure Medical's stock price forecast for 2023? 3 Wall Street research analysts have issued twelve-month target prices for IceCure Medical's stock. Their ICCM share price forecasts range from $3.00 to $4.00. On average, they expect the company's stock price to reach $3.33 in the next twelve months. This suggests a possible upside of 446.2% from the stock's current price. View analysts price targets for ICCM or view top-rated stocks among Wall Street analysts. How have ICCM shares performed in 2023? IceCure Medical's stock was trading at $1.55 at the start of the year. Since then, ICCM stock has decreased by 60.6% and is now trading at $0.6103. View the best growth stocks for 2023 here. Are investors shorting IceCure Medical? IceCure Medical saw a increase in short interest in August. As of August 31st, there was short interest totaling 79,800 shares, an increase of 128.0% from the August 15th total of 35,000 shares. Based on an average daily trading volume, of 139,700 shares, the short-interest ratio is presently 0.6 days. Currently, 0.4% of the company's shares are sold short. View IceCure Medical's Short Interest. When is IceCure Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, December 4th 2023. View our ICCM earnings forecast. How were IceCure Medical's earnings last quarter? IceCure Medical Ltd (NASDAQ:ICCM) posted its quarterly earnings data on Monday, August, 14th. The company reported ($0.09) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.09). The business had revenue of $0.94 million for the quarter, compared to analysts' expectations of $0.80 million. IceCure Medical had a negative trailing twelve-month return on equity of 77.22% and a negative net margin of 486.55%. What is IceCure Medical's stock symbol? IceCure Medical trades on the NASDAQ under the ticker symbol "ICCM." How do I buy shares of IceCure Medical? Shares of ICCM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is IceCure Medical's stock price today? One share of ICCM stock can currently be purchased for approximately $0.61. How much money does IceCure Medical make? IceCure Medical (NASDAQ:ICCM) has a market capitalization of $27.84 million and generates $3.09 million in revenue each year. The company earns $-16,980,000.00 in net income (profit) each year or ($0.39) on an earnings per share basis. How can I contact IceCure Medical? The official website for the company is www.icecure-medical.com. The company can be reached via phone at 972-4623-0333, via email at jeremy@lifesciadvisors.com, or via fax at 972-4623-0222. This page (NASDAQ:ICCM) was last updated on 9/24/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IceCure Medical Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.